Clinical Trial Update: Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care

View source ↗

Summary

A completed clinical trial program in myelodysplastic syndromes focused on genomic characterization to guide clinical decisions and the systematic collection of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Fondazione Italiana Sindromi Mielodisplastiche-ETS | Conditions: MDS (Myelodysplastic Syndrome) | Status: COMPLETED